OncoSec Medical Inc (ONCSQ)

[guti]

The last point of reference for an evaluation is at the 68 million market cap with its last offering. At the time, the investment company felt that a 20% discount was fair and now basically everyone can get the same discount. That would put the estimate share price at $4.40 which can be considered a fair value according to Sabby Investments. Keep in mind, the one trick pony that might come to market before 2019 will be worth a lot more, which adds value to the risk. On the other hand, the share price can go as low as $2 for Oncosec, but I do not think that a back to back reverse split within a 4 year period is in their future, no matter how many times they need to dilute before getting their product to the market. Those two factors will help evaluate the risk.